Podcasts about Medicare

Do people really think they have the right to be rude online? This episode is a raw, unfiltered look at what content creators actually deal with behind the scenes—and why sometimes, blocking is the only option. Follow Mary Jo Here: https://www.youtube.com/@MaryJoIrmen... Get the book: https://www.farmingwithoutthebank.com/book... In this episode, Mary Jo addresses the rising wave of internet trolls, negative comments, and online bullying. From accusations about insurance strategies and retirement planning to criticism about farming, excess money, and even parenting decisions, nothing seems off-limits for keyboard warriors. But here's the truth: creators have the right to protect their space. Mary Jo breaks down real comments she's received, explains the misconceptions around 401(k)s, Roth contributions, Medicare penalties, farming profitability, and the Infinite Banking concept—and shares why mindset matters more than ever. If you've ever wondered why creators delete comments or block followers… this episode explains it all. Key Takeaways: - You don't have the right to be rude just because you're online - Why creators delete and block negative commenters - How retirement withdrawals can increase Medicare premiums - The danger of assuming you "know it all" from one post - Why mindset—not circumstances—often determines financial outcomes - The real cost of online bullying for creators Chapters: (00:00) – Do You Have the Right to Be Rude? (02:00) – Why Are People So Angry Online? (07:15) – 401(k) Withdrawals & Medicare Penalties Explained (13:20) – "What Excess Money?" Farming & Financial Reality (17:50) – Charging Kids Interest & Financial Lessons (24:30) – "Why Isn't the Book Free?" (28:23) – Why I Delete & Block Trolls If you're here to learn and grow, thank you. Be part of the solution, have productive conversations, and scroll past what you don't agree with. Grab your copy of the book here: https://www.farmingwithoutthebank.com/book... Share this episode with someone who needs to hear it—and remember: be a good human.

Lisanne Froon and Kris Kremers came to Boquete, Panama for a fresh start—volunteering, exploring, and soaking up what guidebooks promised was a welcoming mountain town. Then, on April 1, 2014, they step onto the El Pianista trail with a small blue backpack and a plan that should've taken only a few hours. They reach the Continental Divide. They take photos. And then, they don't come back.In Episode 1, Dr. Phil breaks down the known timeline, the geography that can turn one wrong decision into a life-threatening trap, and the earliest digital breadcrumbs, failed emergency call attempts, power-ups that suggest battery conservation, and a pattern that raises one terrifying question: were they simply lost… or were they not alone? Thank you to our sponsors:Diabetes doesn't wait. And the cost of waiting can be devastating. But there is another option you need to know about. Learn more: https://drphildiabetes.comDon't wait! If you're on Medicare or will be soon, reach out to Chapter: Call: (352)-845-0659 or go to https://askchapter.org/ to learn about your Medicare options and get help finding ways to save money.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It was a real privilege and honor to be asked to return to the White House the day after the State of the Union address. Stigall had the opportunity to sit with several members of President Trump‘s cabinet and officials who were happy and eager to talk up the MAGA agenda. Also, issues that may not have been on our radar. We’ve heard many complaints surrounding the concern about President Trump’s executive order protecting the weed killer “Round Up.” You’ll hear a pretty nuanced discussion about it from the HHS Director on Human Food (yes, that’s a real thing.). Dr. Oz and VP Vance launches a broadside on Medicare and Medicare fraud yesterday and we got a preview from Dr. Oz. And what was the online reaction to the President’s speech and the Democrats’ behavior within social media? Our weekly check in with “Eyes Over” to give us the pulse of the voters mood in the digital square. - For more info visit the official website: https://chrisstigall.com Instagram: https://www.instagram.com/chrisstigallshow/ Twitter: https://twitter.com/ChrisStigall Facebook: https://www.facebook.com/chris.stigall/ Listen on Spotify: https://tinyurl.com/StigallPod Listen on Apple Podcasts: https://bit.ly/StigallShow See omnystudio.com/listener for privacy information.

Britney discusses her son's T1D diagnosis, the importance of flexible insulin management, and using Trio. Plus, Scott unveils new calculators for baseline insulin settings and the Warsaw method. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  Free Juicebox Community (non Facebook) Type 1 Diabetes Pro Tips - THE PODCAST Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!

Let us chat about today the inches all around us and also about how there is no market in healthcare all at once in this show. Today I am talking with Ivana Krajcinovic. And let me give you some examples of the inches. Two members of a plan get infusions at a hospital. And if these two members had gone down the street to get their infusions, the total cost of the two of them would have been $1 million less … $1 million less! How many inches is a million dollars? For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Or the examples Ivana Krajcinovic talks about coming up where an independent practice was charging $135 for a chemo infusion and the hospital down the street was charging for the same exact drug, by the way—the same exact infusion—$13,560 … $135 versus $13,560! We talk about affordability in this country? Member's paying coinsurance off that 13K, by the way. And if you're doing the math at home, that is a 10,000% markup. Or if we start from the Medicare price, it was a 40,000% markup. Then there's another example that Ivana talks about where a plan member went to a hospital and got a $90,000 bill for a series of infusions that, again, down the street would have been $185—all in. Inches much? So, it's pretty clear why the show is part of "The Inches Are All Around Us" series. Why do I say this is part of the "No Market" series? Because look, functioning markets rationalize prices. That's just what they do. So, if you have two places in the exact same geography and one of them is charging 500 times or whatever the other one, you don't have a market if they're both still in business a year later. Ongoing wild price variations is a big tell that there's no market to be had. Another tell, though, is that carrier networks, who are supposed to be the demand curve here—or at least that's what their marketing says or what we are all kind of led to believe—they advertise as high-value networks, right? The fact that any given network experiences essentially no business repercussions for spending a million dollars extra of its plan sponsors' (its customers') money—because that's who's paying for this, the self-insured employer or union, at the end of the day—and the network, the carrier network doesn't lose business as a result … Right? Listen to the show from last week with Jacob Asher, MD (Take Two: EP398) about the carrier nonmarket and why this is the case. But bottom line, if anyone is waiting on a market to constrain prices for them, that is very magical thinking. Where this whole thing is gonna wind up, by the way, is with my guest today, Ivana Krajcinovic, suggesting a roadmap to make a whole lot more likely that you'll pay $135 for an infusion instead of 13 grand. For more on this, do go back and listen to the show with Keith Hartman, RPh, by the way. We teed this off a couple of years ago. That was episode 369. But in Ivana's upcoming roadmap that you're gonna hear about (just doubling down on the spoilers—if I'm gonna do something, I might as well do it well), but in that roadmap, direct contracts with indie practices will feature a starring role. I'm telling you this because if you're one of those folks that listens to like 23 minutes of any given podcast and then bails, make sure you make it to around the 30-minute mark of the show. As I have said several times already, my guest today is the incomparable Ivana Krajcinovic, the outgoing vice president of healthcare delivery at UNITE HERE HEALTH. Ivana has just retired, but she spent over three decades with her team protecting the health and the hard-earned wages of 230,000 hospitality workers. She is exactly the kind of "dangerous expert" that we love to have on the show—someone with the wisdom about how the system actually works and the articulate willingness to talk about it. Okay … so, this conversation about the inches and the nonmarket for infusions specifically in this country, for more information, do go back and read the really excellent Bloomberg News exposé by John Tozzi. It's a really good article, and you'll see everything that we talk about today in writing with all the fact-checking that one would expect from Bloomberg News. So, okay … what we'll do in this episode is, first, we're gonna talk about the infusion nonmarket, the inches and its implications, such as an infusion costing 500 times Medicare when there are 1.5x Medicare options in the same exact health system. Sometimes I just can't even with some of this stuff. But another nonmarket tell, again, is that carrier networks are still in business. We talk all about that. What happens next in this episode is we deconstruct the roadmap that Ivana used to fight back, which starts with (no surprises) drilling into data and ends with direct contracting with independent doctors. And how that happens is by carving out utilization management so that there is site-of-care steerage. So, this is a conversation about fiduciary duty. It's a conversation about transparency, the power of collective action. This podcast is sponsored by Aventria Health Group with an assist from Payerset. And I thank Payerset very much for the financial support. Also mentioned in this episode are UNITE HERE HEALTH; Jacob Asher, MD; Keith Hartman, RPh; Stan Schwartz, MD; ZERO.health; John Tozzi; Aventria Health Group; Payerset; Cora Opsahl; 32BJ Union Health Fund; Jonathan Baran; Peter Hayes; Erik Davis; Autumn Yongchu; Brian Cotter; Bright Spot Insights; John Quinn; Mark Newman; Nomi Health; Preston Alexander; Health Here; Ann Lewandowski; HealthCheck360; Sam Flanders, MD; Shane Cerone; Kada Health; and Cristin Dickerson, MD. For a list of healthcare industry acronyms and terms that may be unfamiliar to you, click here.   You can learn more at uhh.org and by connecting with Ivana on LinkedIn.   Ivana Krajcinovic, PhD, recently retired as vice president for healthcare delivery at UNITE HERE HEALTH (UHH), a national Taft-Hartley Fund that purchases healthcare for over 200,000 unionized hospitality workers and their families. Combining her training as a health economist with more than 30 years working directly with immigrants and the working poor, Ivana oversaw a wide variety of projects. She has deep expertise in engaging participants, ranging from benefit education to chronic disease self-management, as well as in developing peer-to-peer programs. Ivana led a team whose challenge was to radically bend the cost curve while maintaining quality coverage as every dollar that UHH spends on healthcare is a dollar that could go to a worker in wages—higher wages that are likely to do more for workers' health than increasing spending on their healthcare. Ivana and her team have utilized narrow networks, value-based contracts, and direct contracting and have established health centers designed for their members. Ivana has a PhD in economics from Yale University and is the author of From Company Doctors to Managed Care: The United Mineworkers' Noble Experiment (Cornell University Press).   00:00 $135 vs $13,560: How infusion drug prices play into the "Inches All Around Us" series. 02:02 How infusion drug pricing fits into the "No Market" series. 03:19 A roadmap and more episodes on this topic. 04:36 Introducing this week's expert, Ivana Krajcinovic, PhD. 05:10 A must-read Bloomberg News article on infusion pricing. 05:33 An overview of what to expect from this episode. 06:54 The first tell of the infusion nonmarket. 07:41 The price variations that Ivana has seen in the infusion nonmarket. 11:39 How hospital spend affects wage increases affects patients and employees twice over. 12:04 EP373 with Cora Opsahl. 13:43 The second tell of the infusion nonmarket. 14:33 Take Two: EP398 with Jacob Asher, MD. 14:55 EP483 with Jonathan Baran. 16:15 Why networks are apathetic to this pricing discrepancy. 17:55 The factors that play into the nonmarket issue of infusion drug pricing variations. 18:26 EP475 with Peter Hayes. 19:18 EP370 with Erik Davis and Autumn Yongchu. 19:45 Are pricing discrepancies easy to spot? 22:38 Where we have power in a nonmarket situation. 23:22 A recap of the advice in the show so far. 23:39 EP493 with John Quinn. 23:41 EP496 with Mark Newman. 25:51 How you place pricing pressure on an entity. 28:47 EP482 with Preston Alexander. 29:34 How an improved market creates time for better care coordination. 30:52 EP486 with Stan Schwartz, MD. 33:23 The fourth part of the roadmap. 36:41 EP492 and EP490 with Sam Flanders, MD, and Shane Cerone. 36:49 Why serving the community and being fiscally responsible should go hand in hand. 38:05 EP500 with Stacey.   You can learn more at uhh.org and by connecting with Ivana on LinkedIn.   Ivana Krajcinovic, PhD, discusses #infusion #drugpricing on our #healthcarepodcast. #healthcare #podcast #financialhealth #commericalpayermarketplace #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Jacob Asher (Take Two: EP398), Stacey Richter (EP500), Dr Jay Kimmel, Mark Noel, Gary Campbell (Take Two: EP341), Zack Kanter, Mark Newman, Stacey Richter (INBW45)

In this video our experts analyze and educate you on what happened and why with fact based, data based, verified and researched expertise reporting. For free and unbiased Medicare help, dial (656) 218-0931 to speak with my trusted partner, Chapter, or go to https://askchapter.org/nez▶ Reach out to me: https://bio.site/professornez▶ ORIGINAL MADE IN U.S.A 250TH AMERICA DESIGNS: https://professornez.myspreadshop.com/▶Support the Channel and Buy us a Coffee: https://buymeacoffee.com/professornez

Tara exposes what may be the largest government fraud scheme in recent U.S. history—stretching from New York to California. Fraud in Plain Sight: A trillion dollars a year in waste and abuse could balance the national budget overnight, yet it continues unchecked. From Medicare home health care to hospice programs, massive payouts are being misused—including benefits to illegal immigrants. The New Economy of Fraud: In New York, personal care services now outpace retail as the top job. In California, federal funds for hospice care and home health services are ballooning, yet patients aren't dying, and providers aren't accountable. Task Force & Accountability: JD Vance leads a new initiative to investigate and stop this fraud, promising tools both for prosecution and prevention. This episode reveals the scale of abuse in government programs, who benefits, and why taxpayers are getting shortchanged.

Tara breaks down the massive scope of alleged fraud in federal programs, the court victories clearing the way for enforcement, and the crucial fight over the SAFE Act. Fraud at Scale: Reports suggest up to $1 trillion a year in Medicare, Medicaid, and other federal program fraud in multiple Democrat-run cities. Trump's Enforcement Wins: Millions removed from food stamps and Medicaid in Republican states, plus a key appeals court ruling allowing IRS data access. The SAFE Act: Pending legislation could force the Democrats to turn over voter rolls, removing ineligible voters and protecting election integrity. Billionaire Wealth & Taxes: Discussion of wealth taxes as a funding mechanism for federal programs and the political resistance to enforcement.

We're marking Rare Disease Month 2026 by highlighting the powerful story of Shanthi Hegde, a young patient advocate working to transform how bleeding disorders are understood, treated, and supported. This work is fueled by her own arduous journey with two rare bleeding disorders and immune dysregulatory syndrome, and an extended diagnostic odyssey marked by dismissal, underdiagnosis, and structural bias. “I was told many times by many providers that these disorders are not common in Indians and that my bruises were there just because I'm brown.” Admirably, Shanthi pushed past this mistreatment, advocated for her medical needs, and devoted herself to tackling a range of issues confronting rare disease patients from mental health access to affordable drug pricing to research equity. In this remarkable Year of the Zebra conversation with host Lindsey Smith, you'll also learn about: Shanti's work with the Hemophilia Federation of America; How gaps extend beyond treatment to include insurance coverage, provider training, and substance use care; What clinicians can do to improve the work they do with rare disease patients. Join us for a conversation that connects patient voice to system change, and explores what real equity for rare disease communities will require. Mentioned in this episode:Hemophilia Federation of AmericaShanthi's LinkedIn Profile If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

CPT 92507 is being deleted and replaced with new time-based speech therapy CPT codes. What does this mean for SLP reimbursement, Medicare billing, work RVUs, and compliance?In this episode of Fix SLP, Jeanette Benigas, PhD, is joined by Rick Gawenda to break down:• Why CPT 92507 was targeted for review• The new proposed speech therapy CPT codes• RUC work RVU recommendations• Practice expense implications• The shift from untimed to timed codes• The risk to auditory processing disorder and communication in the new code language• How audits and payer denials could increase• What SLPs can do before the March 6 open comment periodThe AMA CPT Editorial Panel approved deleting 92507 and creating ten new time-based treatment codes. But what's missing? Language that includes auditory processing disorder, communication, and flexibility for real-world therapy sessions.If you're a speech-language pathologist in private practice, outpatient therapy, pediatrics, hospital, SNF, or home health, this episode explains exactly what is happening and what could change in 2027. This is the episode every SLP needs to hear about CPT 92507.You can find Rick Gawenda on Instagram, TikTok, YouTube, Twitter, Linkedin, and Facebook, or at https://gawendaseminars.com. ✨  Grateful for Beaming Health's partnership in helping clinicians handle insurance so they can focus on patients. Make sure to let them know that Fix SLP sent you! ✨ Register for the directory at speechconnect.org and support the fundraiser that will help launch Speech Connect nationwide.

Country Music Duo, Maddie & Tae, were only 15 years old when they first met. Two young women with a dream of creating music that made an impact and touched the hearts to those who listened to it. Together, as teenagers, these self-described “best-friends and sisters” took on Nashville and became a multi-platinum country duo, who at just 19 years old earned their FIRST Number 1 hit with their debut single, “Girl in a Country Song” – catapulting a successful 12-year career. Just a few months ago, Maddie and Tae made a surprising announcement shocked the country music community and their fans. Maddie and Tae announced that Tae would putting her career on hold to focus on motherhood, and Maddie for the first time since she was a teenager would be exploring a solo career.Thank you to our sponsors:Chapter: Don't wait! If you're on Medicare or will be soon, reach out to Chapter. Call: (352)-845-0659 or go to https://askchapter.org/ to learn about your Medicare options and get help finding ways to save money.NMLS 182334, https://nmlsconsumeraccess.org APR for rates in the 5s start at 6.196% for well qualified borrowers. Call 888-841-1319, for details about credit costs and terms. Or https://americanfinancing.net/PhilSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Trump is facing an uphill climb ahead of his State of the Union speech as his polling continues to fall. Trump plans to announce new policies at tonight's speech. A new report says Trump erased 12 years of Medicare funding. One of Trump's top generals is sounding the alarm on Iran strikes. Republicans are calling for GOP rep. Gonzalez to resign amid affair allegations. A MAGA Senator deleted a post he thought would own the libs. Host: John Iadarola (@johniadarola) ***** SUBSCRIBE on YOUTUBE TIKTOK  ☞        https://www.tiktok.com/@thedamagereport INSTAGRAM  ☞   https://www.instagram.com/thedamagereport TWITTER  ☞         https://twitter.com/TheDamageReport FACEBOOK  ☞     https://www.facebook.com/TheDamageReportTYT

Roger Whitney wraps up the four-part series on navigating health care before Medicare by introducing a practical decision-making framework using the OODA Loop—observe, orient, decide, act—to help you avoid unforced errors and make a confident judgment call. He walks through organizing your retirement cash flow, estimating MAGI and ACA subsidy eligibility, evaluating COBRA, ACA, and private coverage options, and weighing tax optimization against simplicity and continuity of care. He's joined by Taylor Schulte of Define Financial to discuss how professionals navigate Roth conversions, Social Security timing, ACA cliffs, and the trade-offs between optimizing for subsidies versus long-term tax planning.OUTLINE OF THIS EPISODE OF THE RETIREMENT ANSWER MAN(00:00) This show is dedicated to helping you not just survive retirement, but have the confidence to lean in and rock it.(00:30) Roger introduces the final week of the health care before Medicare series and previews upcoming episodes with Harry Reese (co-author of How to Feel Loved) and retirement researcher Wade Pfau.PRACTICAL PLANNING SEGMENT(02:30) Roger reviews the three “heads” that must be managed before Medicare- cost, continuity of care, and complexity.(03:30) Roger talks about avoiding unforced errors that could cost you money, disrupt care, or create unnecessary stress.(05:18) Roger introduces the OODA Loop—observe, orient, decide, act—as a practical way to think step by step about health coverage choices. (05:52) Observe: Build a 5-year retirement income and spending plan, estimate taxes and MAGI, identify where you fall relative to the ACA subsidy cliff, and review withdrawal sources (taxable, pre-tax, Roth) along with future RMD implications.(14:21) Orient: Clarify what matters most to help you make a decision.(20:00) Decide & Act: Choose a direction, document your reasoning, update your plan of record, and implement the distribution strategy that supports your choice.CONVERSATION WITH TAYLOR SCHULTE(22:25) Roger introduces Taylor Schulte from Define Financial(23:15) Why health care before Medicare shouldn't automatically delay retirement and how assumptions often go untested.(26:50) Evaluating alternatives beyond ACA, including COBRA as a short-term bridge and private plans.(31:50) The tension between Roth conversions and ACA subsidies, and how Social Security timing affects MAGI.(34:20) Avoiding the “optimization trap”: sometimes paying more for simplicity still results in a resilient retirement plan.(36:40) The key takeaway is that there's no perfect answer—retirees should explore options, make informed decisions without fear, and use healthcare planning as a tool rather than a barrier or excuse to delay retirement.SMART SPRINT(43:35) Set a reminder to review your health care strategy using a structured approach—especially if retirement or Medicare enrollment is approaching. The goal is to be intentional, not reactive.REFERENCESSubmit a Question for RogerSign up for The NoodleThe Retirement Answer ManKaiser Family Foundation (KFF)Healthcare.govDefine Financial- Taylor SchulteStay Wealthy Retirement Show- Taylor Schulte (podcast)

After the President's State of the Union address, Rep. Josh Gottheimer (D-New Jersey) discusses his party's response to the lengthy speech and underscores the affordability crisis facing many Americans. CNBC's Eamon Javers recaps the evening's highlights, including moments of partisan- and bipartisanship. Then, Centers for Medicare and Medicaid Services administrator Dr. Mehmet Oz discusses the administration's push to lower drug prices. Plus, Anthropic has changed its safety policy.  Rep. Josh Gottheimer - 21:28 Dr. Mehmet Oz - 29:44 In this episode: Josh Gottheimer, @RepJoshG Dr. Mehmet Oz, @DrOz Eamon Javers, @eamonjavers Joe Kernen, @JoeSquawk Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin Cameron Costa, @CameronCostaNY Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

President Donald Trump delivers the 2026 State of the Union Address live to a joint session of Congress at 9 p.m. ET. The theme of tonight's speech is “America at 250: Strong, Prosperous and Respected.” For free and unbiased Medicare help, dial (656) 218-0931 to speak with my trusted partner, Chapter, or go to https://askchapter.org/nez▶ Reach out to me: https://bio.site/professornez▶ ORIGINAL MADE IN U.S.A 250TH AMERICA DESIGNS: https://professornez.myspreadshop.com/▶Support the Channel and Buy us a Coffee: https://buymeacoffee.com/professornezEducational Commentary & Original AnalysisThis channel presents educational, lecture-style analysis created by a university professor and educator. Content focuses on contextual examination, historical background, legal frameworks, and evidence-based analysis of widely reported events, public records, and institutional processes.The approach emphasizes academic methodology, media literacy, and source-driven interpretation rather than advocacy, persuasion, or real-time news reporting. Viewers are encouraged to consult primary sources and form independent conclusions.All content is provided for informational and educational purposes only and does not constitute legal, financial, medical, or professional advice. Views expressed are solely those of the creator.This channel may include references or links to third-party websites or products for informational purposes. Some links may be affiliate links, which may generate a commission at no additional cost to the viewer.All original content is protected by copyright. Fair use applies where permitted by law.#trumpnews #trumpnewstoday #SOTUChapter and its affiliates are not connected with or endorsed by any government entity or the federal Medicare program. Chapter Advisory, LLC represents Medicare Advantage HMO, PPO, and PFFS organizations and stand alone prescription drug plans that have a Medicare contract. Enrollment depends on the plan's contract renewal. While we have a database of every Medicare plan nationwide and can help you to search among all plans, we have contracts with many but not all plans. As a result, we do not offer every plan available in your area. Currently we represent 50 organizations which offer 18,160 products nationwide. We search and recommend all plans, even those we don't directly offer. You can contact a licensed Chapter agent to find out the number of products available in your specific area. Please contact Medicare.gov, 1-800-Medicare, or your local State Health Insurance Program (SHIP) to get information on all of your options.

This week, we explore a new standard of care for high-risk HER2-positive early breast cancer, long-acting therapy for people with HIV facing adherence challenges, a first-in-class trial of a p53 reactivator, and tecovirimat for mpox. We review group B streptococcal disease and a revealing case of prosthetic joint infection. Perspectives examine the role of folate therapy, Medicare drug-price negotiation, AI in medical education, and incidental findings.

In the final episode of this three-part series, Dr. Stacey Clardy and Max Goldman talk about telehealth.  Stay updated with everything related to Neurology on the Hill. Show transcript:  Dr. Stacey Clardy: Hi, this is Stacey Clardy, and today we're wrapping up our three-part series covering the Top Advocacy Issues for Neurology on the Hill 2026 in Washington, DC. This is the event where many neurologists fly in from all over the country to meet with our elected representatives to discuss the issues of the most importance to our patients, and to allow us to continue to take good quality care of our neurology patients. We have again back with us, Max Goldman. He's the Director of Congressional Affairs from the AAN Legislative Team. Max, we covered Medicare, we covered neuroscience research in the Brain Initiative. The third and final issue is telehealth. What do we need to accomplish on telehealth in Washington, DC this year? Max Goldman: The telehealth flexibilities provided with the COVID-19 public health emergency have been so important to providing neurological care to patients across the country. However, what we saw during the government shutdown at the end of 2025 was a lapse in those flexibilities, which caused a huge amount of panic, of uncertainty for both our members, the AAN, who are providing care, and patients who relied on care through telehealth from their neurologist. That can't happen again. These flexibilities have been extended short-term basis for one year, two year, a couple of months, and what we need now is a permanent extension of these flexibilities so they can't lapse again, and our patients know they can access the care they need. What we're doing at Neurology on the Hill is going to ask our members of Congress to co-sponsor the Connect for Health Act. This bill would permanently extend telehealth flexibilities, including a full extension of protection of audio-only visits, which is important for folks in areas without great broadband or access to internet. This would just be a really good bill. It's got a lot of momentum this year, and we're hopeful that this will finally make telehealth a permanent part of neurological care going forward. Dr. Stacey Clardy: So important. I certainly know out here in Utah where we cover several rural states, this has really been a lifeline to our patients. To learn more about this issue and the other issues being discussed at Neurology on the Hill, you can go to AAN.com and click on advocacy. Thanks for listening, and thank you Max, for representing us in DC.   

If your payroll keeps climbing but reimbursement isn't, something has to change. In this episode, Brian sits down with Wendy Lucas from Highbridge to break down how a remote PT front desk powered by a virtual team can stabilize staffing, improve patient experience, and protect your margins — without sacrificing the human touch. They discuss the real pain points practice owners face: turnover, call-outs, inconsistent collections, Medicare concerns, and rising administrative costs. More importantly, they explain how a live, tech-enabled front desk model can reduce overhead, increase consistency, and help you build a leaner, more profitable practice. If you're serious about lowering payroll, improving operational stability, and modernizing your PT front office, this is a conversation you don't want to miss.  

If you'd like to work with us on your Medicare health plan, we're licensed in 45 states and actively helping clients across the country. Christian and the team at Everything Senior Insurance represent many of the top insurance companies in the Medicare space. We're happy to help—just reach out! ➡️ Visit our site: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.eseniorinsurance.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠✅ Call us: (801) 255-5340

After the grind of Annual Enrollment, the reality of lock-in can be a little defeating, even for the most seasoned agents. If you've been feeling that way, listen to learn more about Special Needs Plans and their place in your post-AEP strategy.   Read the text version  

In 1997, Bill Clinton and Newt Gingrich shocked Washington by coming together to pass the Balanced Budget Act — a bipartisan deal that led to the first federal budget surplus in nearly 30 years.But what did it really change?This episode breaks down how the BBA cut $112 billion from Medicare, reshaped Medicaid, created Medicare+Choice (now Medicare Advantage), introduced the Sustainable Growth Rate (SGR), and paired healthcare cuts with $95 billion in tax breaks.Was it fiscal responsibility… or the beginning of a long-term shift toward privatization?We're diving into the 1995 government shutdown, the “Third Way,” rural hospital impacts, the Doc Fix crisis, and what critics like Bernie Sanders warned about on the House floor.www.stayskeptical.comWise Wolf Gold: https://www.wolfpack.gold/?ref=jvujkwgsSources: https://docs.google.com/document/d/1jcwvgWpPz8GqLxNwpeJM7AHqBJL2O3JWVdE8ggKK7_8/edit?usp=sharingwww.stayskeptical.comWise Wolf Gold: https://www.wolfpack.gold/?ref=jvujkwgsSources: https://docs.google.com/document/d/1jcwvgWpPz8GqLxNwpeJM7AHqBJL2O3JWVdE8ggKK7_8/edit?usp=sharing

Dr. Friday explains why inherited property can receive a step-up in basis, which may reduce future taxes. She cautions that quitclaiming property to children early can be a poor tax decision and mentions the Medicare or Medicaid look-back rules. Transcript G’day, I’m Dr. Friday, president of Dr. Friday’s Tax and Financial Firm. To get more info, go to www.drfriday.com. This is a one-minute moment. Step-up in basis for inherited properties: seems to be a misconception out there of how this works. Because a lot of times I talk to someone and they’re like, oh no, I quitclaim my property to my children, so I knew they would get it. That is not a good tax decision. It may be a mental or physical or some other kind of decision, but you know, there’s a five-year look back from Medicare or Medicaid. Therefore, unless it’s gonna be something that happens after that, you really just want to let them inherit. And you know that also applies if a husband and wife own joint property, half of them dies, the other half can get a step-up. Need help? Call me. You can catch the Dr. Friday Call-in Show live every Saturday afternoon from 2 to 3 p.m. right here on 99.7 WTN.

Novo Nordisk announced on Tuesday that it plans to cut the list prices of its blockbuster weight-loss and diabetes drugs Ozempic and Wegovy by up to fifty percent starting January first, twenty twenty-seven. The Danish company stated that various doses of these medications, which contain the active ingredient semaglutide, will drop to six hundred seventy-five dollars per month. This represents a fifty percent reduction for Wegovy and a thirty-five percent cut for Ozempic, with the same price applying to Rybelsus pills. Fox Business reports that Novo Nordisk executive Jamey Millar explained the move aims to help more than one hundred million Americans with obesity and thirty-five million with type two diabetes by lowering out-of-pocket costs, especially for those on high-deductible health plans. CBS News notes this comes amid fierce competition from rivals like Eli Lillys Mounjaro and Zepbound, as well as cheaper compounded versions from telehealth providers. The price slash will align with lower Medicare rates for older Americans but will not affect direct-to-consumer prices, where Wegovy already sells for three hundred forty-nine dollars.In related news, Oprah Winfrey has shared fresh insights on her use of GLP-one medications like those in the Ozempic family. In a recent NBC Connecticut discussion tied to her book Enough, co-authored with Yale Obesity Research Center director Doctor Ania M. Jastreboff, Winfrey reflected on stopping the shots cold turkey on her seventieth birthday in January twenty twenty-four after gaining clarity that obesity drives overeating due to the bodys enough point, a genetically influenced weight set point. She tried maintaining her loss through diet and exercise alone but regained twenty pounds over twelve months, realizing these drugs are a lifelong tool, much like blood pressure medication. Doctor Jastreboff emphasized in the interview that the medications recalibrate this enough point in the brain, reducing hunger signals and fat storage, countering the bodys drive to regain weight. Winfrey, who pays out of pocket for friends unable to afford the shots, urges ending shame around obesity, calling it a disease not a personal failing. She stresses combining drugs with healthy habits for sustainable health, not just looks.These developments highlight growing accessibility and realism around GLP-one drugs amid evolving expert views.Thanks for tuning in, listeners, please subscribe, come back next week for more, and remember this episode was brought to you by Quiet Please podcast networks. For more content like this, please go to Quiet Please dot Ai.Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Michael Schwartz is a veteran defense attorney with over 30 years of trial experience, widely known for representing law enforcement officers in high-profile use-of-force and on-duty shooting cases throughout Southern California. Over his career he has secured full acquittals in some of the most closely watched excessive-force prosecutions, including the manslaughter trial of a Los Angeles sheriff's deputy, federal excessive-force charges for a Pomona corporal, and other defenses in nationally publicized on-duty shootings that drew intense media attention. Schwartz gives his reaction to the fatal shooting of Minneapolis resident Renée Good by an ICE agent and the death of Alex Pretti. Thank you to our sponsors:Diabetes doesn't wait. And the cost of waiting can be devastating. But there is another option you need to know about. Learn more: https://drphildiabetes.comDon't wait! If you're on Medicare or will be soon, reach out to Chapter: Call: (352)-845-0659 or go to https://askchapter.org/ to learn about your Medicare options and get help finding ways to save money.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Jen recounts her T1D diagnosis at age 29 and opens up about the emotional challenges of navigating family dynamics lacking understanding and support. Go tubeless with Omnipod 5 or Omnipod DASH * Dexcom G7 CONTOUR NextGen smart meter and CONTOUR DIABETES app Get your supplies from US MED  or call 888-721-1514 Tandem Mobi  Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Touched By Type 1 Take the T1DExchange survey Type 1 Diabetes Pro Tips - THE PODCAST Use code JUICEBOX to save 40% at Cozy Earth  Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! * Omnipod Wilmot E, et al. Presented at: ATTD; March 19-22, 2025; Amsterdam, NL. A 13-week randomized, parallel-group clinical trial conducted among 188 participants (age 4-70) with type 1 diabetes in France, Belgium, and the U.K., comparing the safety and effectiveness of the Omnipod 5 System versus multiple daily injections with CGM. Among all paid Omnipod 5 G6G7 Pods Commercial and Medicare claims in 2024. Actual co-pay amount depends on patient's health plan and coverage, they may be higher or lower than the advertised amount. Source IQVIA OPC Library. Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan. 

Infusion services make up a roughly $150 billion market in the U.S., and underpin the financial stability of major service lines, especially oncology. Historically, health systems have enjoyed strong volumes, favorable reimbursement, and access to 340B discounts that keep their infusion business profitable. But rising competition, payer and employer driven site of care shifts, and looming policy changes are putting pressure on what many leaders have relied on as a stable, margin accretive business. In this episode, host Abby Burns sits down with Advisory Board expert Chloe Bakst to break down what's actually happening in the infusion market — and why every health system leader should be paying closer attention. Together, they explore how new competitors are capturing leakage you may not even see, how payers and employers are steering patients away from hospital outpatient departments, and how upcoming 340B reforms and Medicare drug price negotiations could reshape the economics of infusion over the next three years. Chloe also shares the strategies forward thinking systems are using to protect their infusion business and prepare for rapidly emerging headwinds. We're here to help: Webinar | The top trends in today's infusion market Tool | Market Scenario Planner Ready-to-Use Resource | Policy Scenario Impact Calculator Expert Insight | The 3 trends reshaping the specialty drug pipeline today Podcast | 270: Service line snapshot: What every health leader needs to know Webinar | Join Optum Advisory experts at this upcoming webinar to learn how optimizing patient access unlocks the value of digital innovations and drives long-term sustainability. Expert Insight | How data-driven risk reduction protects patients and providers A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big updates for stem cell and islet transplants, new pen option for Zepbound, an implantable insulin pump moves forward and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: I'm just back from MNO DC and I'm exhausted. But it's the best kind of tired. We had an incredible time – hope you can join us in Nashville. With a reminder that we have our first Club 1921 in Nashville – that's our educational dinner series for HCPs and patient leaders. All the info is over at diabetes-connections.com events/     Okay.. our top story this week: XX An "immune system reset" eliminated Type 1, diabetes in mice in a study conducted at Stanford Medicine without immune suppressant medications. This was a combined transplant of blood stem cells and insulin-producing pancreatic islet cells from a donor whose immune profile did not match the recipient. The dual transplant approach both restored insulin production and retrained the immune system. For the full six months of the experiment, the animals did not need insulin injections or immune suppressive medications. Challenges remain using this approach to treat Type 1 diabetes. Pancreatic islets can be obtained only after death of the donor, and the blood stem cells must come from the same person as the islets. It is also unclear whether the number of islet cells typically isolated from one donor would be enough to reverse established Type 1 diabetes. But the researchers are working on solutions, which could include generating large numbers of islet cells in the laboratory from pluripotent human stem cells, or finding ways to increase the function and survival of transplanted donor islet cells. https://scitechdaily.com/stanford-scientists-cure-type-1-diabetes-in-mice-without-insulin-or-immune-suppression/ XX An electronic implant interlaced with islet cells is being looked at to treat type 1. Researchers at the University of Pennsylvania School of Medicine worked with engineers at Harvard University to combine stem-cell biology with soft electronics. They inserted an ultrathin, flexible mesh of conductive wires — thinner than a human hair — into developing pancreatic tissue. As the cells assembled into clusters, the mesh became woven through them. The electronics can record the faint electrical signals produced by the cells that control insulin release. They can also deliver small pulses of electricity back to the cells.   After several days, the cells began to behave more like mature islets. Their internal signalling shifted, neighbouring cells started working in concert and insulin release became stronger and better timed.  Very early on here – and the transplanted cells still need to be protected from being attacked by the immune system. https://www.thetimes.com/uk/science/article/first-cyborg-pancreas-implants-type-1-diabetes-nxkv8r0fp?gaa_at=eafs&gaa_n=AWEtsqeJYYUF9TMR-GgGUG92hPyog-ISeiqGIgdyaaIKKcpvhtoftGiUaaOtQeG0NWI%3D&gaa_ts=699c50d4&gaa_sig=w-PQ0ArosZSznYDSWEzt8aQg4WC0FF5ZFRt9NedO5sSTL2FyWzupH8eSG7RCy2S8TQnlHOeKCudANWm1MNI59w%3D%3D XX Katie Beth (hand) Eledon trial – aaron kowalski post linkedin. Last fall we told you about promising results from Eledon's drug to prevent islet transplantation rejection in type 1 diabetes. The first six patients no longer had to inject or infuse insulin.. the trials continue and this month one of the patients – Katie Beth Hand – began posting about her experiences one month in, on social media, she says she's off basal insulin already and in range 99 percent of the time. She is also encouraging people to learn more about support the islet act https://lnkd.in/e8pQ7_Y7 XX This is a bill introduced last November which would change the wording on pancreatic cell transplants. The problem is that islets are classified as drugs rather than organs, making transplantations difficult for medical teams and centers to preform due to accessibility. Insurance companies are also less likely to provide reimbursements for treatment, which can cost hundreds of thousands of dollars. The official Journal of The Transplantation Society estimates the cost at about $140,000. The bill went to the senate committee of Health, Education, Labor, and Pensions in early November. No other action has been taken since then. https://www.wtoc.com/2026/02/19/bluffton-family-advocates-islet-act-help-diabetic-son/ XX Big change for the obesity drug Zepbound – now available in the multi dose KwikPen. This is a month's worth of doses in a single pen.. and it's multi dose – you can adjust it. Cash-paying patients can get the multi-dose device, called KwikPen, on the company's direct-to-consumer website, LillyDirect. Prices start at $299 per month for the lowest dose level. Until now, you could only get zepbound in a single dose auto injector or a sing dose vial. In a release, Lilly said the Food and Drug Administration approved a label expansion for Zepbound to include the multi-dose device. The KwikPen is already used for other drugs, such as Lilly's popular diabetes medication, Mounjaro – which is the same medication as zepbound, they're both tirzepitide. https://www.cnbc.com/2026/02/23/eli-lilly-launches-zepbound-obesity-drug-pen-one-month-doses.html   XX For years, researchers have observed that people who live at high elevations,  tend to develop diabetes less often than those at sea level. Although the trend was well documented, the biological explanation behind it was unclear. Scientists now say they have identified the reason. Their research shows that in low oxygen environments, red blood cells begin absorbing large amounts of glucose from the bloodstream. Their work showed that when oxygen is limited, red blood cells use glucose to generate a molecule that helps release oxygen to tissues. This process becomes especially important when oxygen is in short supply. The researchers also found that the metabolic benefits of prolonged hypoxia lasted for weeks to months after mice were returned to normal oxygen levels. They then evaluated HypoxyStat, a drug recently developed in Jain's lab that mimics low oxygen exposure. HypoxyStat is taken as a pill and works by causing hemoglobin in red blood cells to bind oxygen more tightly, limiting the amount delivered to tissues. In mouse models of diabetes, the medication completely reversed high blood sugar and outperformed existing treatments. https://www.sciencedaily.com/releases/2026/02/260221060952.htm XX Watching this one closely – Portal Diabetes gets FDA breakthrough device designation for its implantable insulin pump system. This is a system that includes not just a device that's implanted into the abdomen, but also a new, temperature stable insulin. It will work with – quote – "modern" CGM technology with a fully closed loop - and aims to deliver a functional cure for type 1. While reports say Portal's system is the first in the US – there was an implantable pump developed and used by about 500 people worldwide, including about 100 in the US – by MiniMed. Medtronic bought the company and in 2007 they stopped that program. Portal Diabetes expects to begin clinical trials on its combination system around the fourth quarter of 2027. https://www.drugdeliverybusiness.com/portal-diabetes-fda-breakthrough-implantable-insulin-pump/ XX Sequel Med Tech and Senseonics (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration. That's the eversense cgm and twist pump. Sequel said its full launch with Eversense 365 makes twiist available with two compatible CGMs. twiist also pairs with the Abbott FreeStyle Libre 3 Plus sensor. Eversense 365, an implantable system, rests under the skin for the duration of a year. Users can change its external, silicone-based adhesive daily with almost no skin reactions. https://www.drugdeliverybusiness.com/sequel-senseonics-full-launch-twiist-eversense/ XX Right back with a Dexcom update, and a look at which type of diet reduces insulin use overall.. right after this: -- Back to the news.. Dexcom is watching for expanded Medicare coverage of its continuous glucose monitors to people with Type 2 diabetes who don't take insulin. CEO Jake Leach told investors on Thursday that the company has been "sitting here waiting for a coverage decision" from the Centers for Medicare and Medicaid Services Dexcom started to see commercial coverage unlock for Type 2, non-insulin users toward the end of last year, Leach said. He expects broader Medicare coverage for that group would allow nearly 12 million people to access CGMs.     In the meantime, the American Diabetes Association updated its guidelines last year to recommend clinicians consider using CGMs for Type 2 diabetes when patients are taking glucose-lowering medications other than insulin. Leach said that real world data the company has been generating supports that decision, and that Dexcom has launched a registry for non-insulin users. https://www.medtechdive.com/news/dexcom-seeks-expanded-medicare-coverage-of-cgms-for-type-2-diabetes/812223/ XX Medtronic's separation of MiniMed is not yet complete.. but continues to move forward. The company has submitted their next pump – MiniMed Flex – to the FDA. This is a pump smaller than the 780G but uses the same reservoirs and infusion sets. It will also work with both the Simplera Sync and Instinct sensors. Medtronic also began a U.S. pivotal study for Vivera, its third-generation algorithm for automated insulin delivery. It also remains set to submit its MiniMed Fit patch pump system to the FDA by the coming fall. https://www.drugdeliverybusiness.com/medtronic-submits-minimed-flex-fda-q3/ XX A study modelling how genes may influence a child's body mass index over time has found that BMI at age 10 and overall growth rate between ages one and 18 might be important factors, as the two are more likely linked to diabetes, high cholesterol, and heart disease in later life. Nearly 66,000 BMI measurements from around 6,300 children and adolescents aged one to 18 were analysed to understand the role of genes.     "Future research is needed to help identify the most effective ages to prevent obesity or poor growth for long-term benefit." https://www.ndtv.com/health/bmi-at-age-10-growth-rate-up-to-age-18-are-important-factors-for-diabetes-heart-disease-study-11125146 XX A low-fat vegan diet—without cutting calories or carbs—may help people with type 1 diabetes significantly reduce how much insulin they need. In a new analysis published in BMC Nutrition, participants following the plant-based plan lowered their daily insulin use by 28%, while those on a portion-controlled diet saw no meaningful change. Researchers say the reduced insulin requirement likely reflects improved insulin sensitivity. The original 2024 study reported additional benefits from the vegan diet. Participants lost an average of 11 pounds and showed improvements in insulin sensitivity and glycemic control. Cholesterol levels and kidney function also improved among those following the plant-based plan. https://www.sciencedaily.com/releases/2026/02/260212234212.htm XX Interesting little tidbit from the Winter Olympic Games.. the World Anti-Doping Agency (WADA) was monitoring GLP drug use. An advisory group that makes recommendations about WADA's list of prohibited substances discussed the status of GLP-1 medications, and added semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) to its monitoring program That means patterns of use of these drugs will be tracked both in and out of competition.  The finding will be used to make recommendations about whether GLP-1 agonists should be added to the prohibited list, the spokesperson explained. While GLP-1 drug use is not currently prohibited, that could change before the next Summer Olympic Games in Los Angeles in 2028, he noted. https://www.medpagetoday.com/popmedicine/cultureclinic/119770 XX That's it for in the news!

NEW VIDEO by Savannah Guthrie Offers $1 MILLION in Nancy Guthrie case. In this video our experts analyze and educate you on what happened and why with fact based, data based, verified and researched expertise reporting. For free and unbiased Medicare help, dial (656) 218-0931 to speak with my trusted partner, Chapter, or go to https://askchapter.org/nezNancy Guthrie Case FULL PLAYLIST: https://www.youtube.com/playlist?list=PLpTZH0fRT3fBo8td0iDOdJwFcPyIVAAEv▶ Reach out to me: https://bio.site/professornez▶Support the Channel and Buy us a Coffee: https://buymeacoffee.com/professornezEducational Commentary & Original AnalysisThis channel presents educational, lecture-style analysis created by a university professor and educator. Content focuses on contextual examination, historical background, legal frameworks, and evidence-based analysis of widely reported events, public records, and institutional processes.The approach emphasizes academic methodology, media literacy, and source-driven interpretation rather than advocacy, persuasion, or real-time news reporting. Viewers are encouraged to consult primary sources and form independent conclusions.All content is provided for informational and educational purposes only and does not constitute legal, financial, medical, or professional advice. Views expressed are solely those of the creator.This channel may include references or links to third-party websites or products for informational purposes. Some links may be affiliate links, which may generate a commission at no additional cost to the viewer.All original content is protected by copyright. Fair use applies where permitted by law.#nancyguthrie #guthrie #nancyguthriecaseChapter and its affiliates are not connected with or endorsed by any government entity or the federal Medicare program. Chapter Advisory, LLC represents Medicare Advantage HMO, PPO, and PFFS organizations and stand alone prescription drug plans that have a Medicare contract. Enrollment depends on the plan's contract renewal. While we have a database of every Medicare plan nationwide and can help you to search among all plans, we have contracts with many but not all plans. As a result, we do not offer every plan available in your area. Currently we represent 50 organizations which offer 18,160 products nationwide. We search and recommend all plans, even those we don't directly offer. You can contact a licensed Chapter agent to find out the number of products available in your specific area. Please contact Medicare.gov, 1-800-Medicare, or your local State Health Insurance Program (SHIP) to get information on all of your options.

In the second installment of this three-part series, Dr. Stacey Clardy and Max Goldman discuss neuroscience research and the BRAIN Initiative.  Stay updated with everything related to Neurology on the Hill. Show transcript:  Dr. Stacey Clardy:  Hi, this is Stacey Clardy. We are going to continue with our three-part series today about the top advocacy issues covered at Neurology on the Hill 2026 in Washington, DC. Again, as many of you know, this is the AAN's annual advocacy fly-in event. Neurologists come from all over the US to Washington and meet with elected representatives to discuss issues of high importance to allow us to continue providing high-quality care to patients in the US with neurological diseases. In the first minute, we discuss the topic of Medicare, and I have with me again, Max Goldman, director of Congressional Affairs from the AAN legislative team, to talk to us about issue number two, which is neuroscience research, and specifically the BRAIN Initiative. Max, what are we going to discuss about neuroscience research? What do we need to happen in order to continue doing high-quality research? Max Goldman: So, this one is so important, and there's this wonderful program at the NIH called The BRAIN Initiative. This was founded in 2013, really reinforced in 2016 with the 21st Century Cures Act. It's just funding for basic research into how the brain works, right? And the idea behind this is that if we can understand how the brain works, we can find the next generation of treatment or cures for neurological conditions, psychiatric conditions, and issues that go through the brain. This year, we are in a precarious position. Mandatory funding for this program is expiring, and so we're going to lose a lot of money and a lot of opportunities to provide more grants to people to figure out how the brain works. So, what we are doing on Neurology on the Hill is we're asking members of Congress to support $468 million in funding in fiscal year 2027 for the BRAIN Initiative, so we can keep up the good work and keep working towards the next generation of treatments and cures for neurological conditions. Dr. Stacey Clardy: So important. Thank you, Max. To learn more about this issue and the other two issues, you can go to AAN.com. Click on advocacy. And stick with us for the third Neurology Minute, where we will get to the final issue to be discussed, telehealth. 

In this Tax Tuesday episode, Anderson's Barley Bowler, CPA, and Eliot Thomas, Esq., address listener questions on a wide range of tax strategies for real estate investors, business owners, and healthcare professionals. They explain how seller financing affects the ability to use cost segregation and bonus depreciation under IRC Section 465's at-risk rules, and how a single-member LLC can recoup startup education costs through a C Corporation structure with shareholder loans. Barley and Eliot walk through the powerful tax advantages of setting up a management C Corporation over a Wyoming holding company — including medical reimbursements, accountable plan deductions, and W-2 solo 401(k) options. They cover what Medicare premiums and COBRA costs are reimbursable through a C Corp's medical reimbursement plan, how the Section 121 exclusion works for primary residence sales, and what options exist for mitigating a seven-figure business sale gain. Other topics include write-offs for uncollected insurance balances in healthcare practices, avoiding required minimum distributions by rolling into an employer plan, and electing pass-through entity tax in New York for investment partnerships. Tune in for expert guidance on these strategies and more! Submit your tax question to taxtuesday@andersonadvisors.com Highlights/Topics: 7:18 — "How does the use of seller financing impact the ability to use strategies such as cost segregation and bonus depreciation?" Under IRC Section 465, your deductible losses are limited to the amount you have personally at risk. First phrase: "This is a great question. This covers a lot of different angles." 15:27 — "The business failed to make any profit in year 1. How are those initial costs recouped, and how much can be carried forward to future years?" A C Corp election allows full education deductions; fund via shareholder loan for tax-free recoupment. First phrase: "A single member LLC spent $9,500 on training and other related startup costs." 21:06 — "If I operate one LLC per real estate project, does it make sense to have a separate management entity to deduct shared expenses like an assistant, office costs, business meals, travel, and pre-development work? What's the correct tax structure?" A management C Corporation reduces rental income and allows tax-free reimbursements to the owner. First phrase: "If I operate one LLC per real estate project, does it make sense to have a separate management entity..." 27:45 — "What components of Medicare premiums are reimbursable by my property management C corporation?" Out-of-pocket Medicare and COBRA premiums qualify; general wellness supplements typically do not. First phrase: "What components of Medicare premiums are reimbursable by my property management C Corporation..." 38:10 — "If I sell my house, how long do I have to buy something else before I owe capital gains tax? Do I need to purchase the next home for more than the sale of the house or is there a percentage of that value?" Section 121 excludes up to $250K single or $500K married with no replacement property required. First phrase: "If I sell my house, how long do I have to buy something else before I owe capital gains tax?" 44:45 — "For my healthcare practice, where can I write off balances that insurance refuses to pay, and promotions/certain population deals where I give service discounts or free visits/supplement packages for charity events?" Cash-basis taxpayers cannot deduct uncollected income, and donated services are not tax-deductible. First phrase: "For healthcare practice, where can I write up balances? Insurance refuses to pay." 50:02 — "Can I avoid taking Required Minimum Distributions at age 73, if I roll over my retirement contributions from a previous employer's plan to my current employer's plan?" Rolling into a current employer plan may defer RMDs if you are not a greater-than-5% owner. First phrase: "Can I avoid taking required minimum distributions at age 73?" 53:12 — "Can an investment partnership elect the Pass Through Entity Tax in New York? What are the issues creating/dissolving investment partnerships?" New York allows any partnership to elect PTET, generating a valuable federal-level tax deduction. First phrase: "Can an investment partnership elect the pass through entity tax in New York?" 59:38 — "I sold my company, and I am coming into a 7-figure settlement soon. What can I do with that money to decrease my taxes?" Explore charitable remainder trusts, qualified opportunity zones, and capital loss harvesting strategies. First phrase: "I sold my company and I'm going to come into a seven figure settlement soon." Resources: Tax and Asset Protection Events — Live workshop in Las Vegas, March 19–21 https://andersonadvisors.com/real-estate-asset-protection-workshop-training/?utm_source=how-to-structure-a-tax-efficient-management-entity&utm_medium=podcast Schedule Your FREE Consultation — Scan the QR code or visit the link to book your strategy session https://andersonadvisors.com/strategy-session/?utm_source=how-to-structure-a-tax-efficient-management-entity&utm_medium=podcast Anderson Advisors https://andersonadvisors.com/ Toby Mathis YouTube https://www.youtube.com/@TobyMathis Toby Mathis TikTok https://www.tiktok.com/@tobymathisesq Clint Coons YouTube https://www.youtube.com/@ClintCoons

Building new cash-pay services can be one of the fastest ways to grow a private practice — or one of the fastest ways to create legal, compliance, and licensing risk if it's done wrong.In this episode of the Private Practice Owners Podcast, host Adam Robin sits down with Daniel Hirsch, CEO and Founder of Risk & Compliance Analytics, for an action-packed installment of the Compliance Marathon — a series designed to help owners stop fearing compliance and start using it strategically.Daniel breaks down what most practice owners misunderstand about cash-pay services — including the dangerous assumption that “cash means no rules.” From Medicare landmines to pricing consistency, documentation requirements, and licensing exposure, this conversation gives owners a clear framework for expanding cash services without putting their practice, revenue, or license at risk. Together, they unpack:Why cash-pay services are not “rule-free” — and where risk actually increasesThe biggest Medicare mistake owners make when offering cash servicesHow inconsistent pricing, discounts, and “buddy deals” create legal exposureWhy documentation requirements still apply — even when insurance isn't involvedHow to clearly separate cash services from covered therapy to avoid compliance overlapWhat must be transparent: pricing, good-faith estimates, refunds, and consentWhy protecting your license should always come before chasing new revenueCommon gray areas where practices get burned — including “free” screeningsThe simple steps every owner should take before launching wellness, performance, or specialty cash programsHow to build cash services that are compliant, defensible, and scalable This is not a lecture on rules — it's a practical roadmap for owners who want to grow aggressively and responsibly. If you're thinking about adding wellness programs, memberships, dry needling, laser therapy, women's health services, or any cash-pay offering, this episode will save you time, money, and future headaches.

Jeremy Keil explains the 5 RMD (Required Minimum Distribution) mistakes in Retirement and how to avoid them. A retiree recently called for help. It was their first year taking Required Minimum Distributions. They had delayed their first RMD until April of the following year — which meant taking two distributions in one tax year. That part was allowed. In some cases, it can even be strategic. But when they called their IRA custodian and asked, “How much should I withhold for taxes?” they were given the default answer: 10% federal withholding. They assumed that must be right. It wasn't. They ended up short on taxes by more than $10,000 — and owed penalties on top of that. That situation wasn't caused by breaking a rule. It was caused by following the rule without a plan. And that's where most RMD mistakes begin. I recently wrote an article for Kiplinger magazine titled “5 RMD Mistakes That Could Cost You Big-Time: Even Seasoned Retirees Slip Up” and for this week's episode of the “Retire Today” podcast I decided to talk through each of these mistakes in detail. Mistake #1: Waiting Until Age 73 to Create a Plan Turning 73 is not a strategy. If you wait until the government forces your first RMD to think about it, you've already missed years of opportunity. The window between retirement and RMD age is often the most flexible tax-planning period of your life. In those years, you may have: Lower earned income No required withdrawals yet Control over when and how you take distributions That's prime territory for intentional tax planning. Once RMDs begin, you've lost some flexibility. In the KEEP step of the Retirement Master Plan, tax timing matters. RMDs don't happen in isolation. They interact with Social Security, pensions, and brokerage income. Planning ahead—sometimes a decade ahead—can dramatically change the long-term outcome. Mistake #2: Failing to Make Use of Qualified Charitable Distributions (QCDs) This one surprises me every year. RMDs currently begin at age 73 (moving to 75 for those born in 1960 or later). But Qualified Charitable Distributions still start at 70½. That means you can send money directly from your IRA to a charity before RMDs even begin. Why does that matter? Because a QCD: Reduces your IRA balance (lowering future RMDs) Keeps the distribution out of your taxable income May help limit Social Security taxation May help reduce Medicare premium surcharges Many retirees continue writing checks to charities from their checking account, hoping for a deduction. With today's larger standard deduction, many people don't itemize at all. Going directly from IRA to charity is often more tax-efficient—and sometimes dramatically so. If charitable giving is already part of your plan, the tax strategy should be part of it too. Mistake #3: Doing the Wrong Tax Withholding When retirees call their custodian to take their RMD, they're often asked: “How much would you like withheld for taxes?” The default federal withholding is often 10% for IRAs and 20% for 401(k)s. Many people assume, “That must be right.” It often isn't. I recently saw a retiree who delayed their first RMD until April of the following year—which meant taking two distributions in one year. They defaulted to 10% withholding. They ended up underpaying taxes by more than $10,000 and owed penalties. The custodian can't provide tax planning. That's not their role. Before taking an RMD, you need to project: What tax bracket you'll land in Whether additional withholding is necessary How this affects your overall estimated payments Again, this falls under the KEEP step. Don't let the default settings dictate your tax bill. Mistake #4: Not Realizing How Your RMD Income Affects the Rest of Your Tax Return RMDs don't just increase taxable income. They can: Make more of your Social Security taxable Push capital gains from 0% into taxable territory Trigger Medicare IRMAA surcharges Many retirees focus only on their marginal bracket. But the real issue is tax cost, not tax bracket. An extra $20,000 RMD might not just be taxed at 22%. It could cascade into additional taxation elsewhere. That's why projections matter. You don't want to discover these ripple effects after the fact. Mistake #5: Forgetting That the M in RMD means ‘Minimum,' not ‘Maximum' The M in RMD stands for minimum. It does not mean that's the only amount you're allowed to withdraw. You can: Withdraw more than your RMD Complete Roth conversions after satisfying the RMD Send more than your RMD amount to charity (subject to QCD limits) Sometimes taking more than the minimum makes sense—especially if it smooths taxes over multiple years. RMDs are a rule. They are not a retirement strategy. The Bigger Lesson RMDs are not just a government requirement. They are a planning opportunity—or a planning hazard. They affect your income plan (MAKE), your spending plan (SPEND), your tax strategy (KEEP), and even what you ultimately LEAVE behind. The biggest mistake isn't misunderstanding a rule. It's treating RMDs as an isolated event instead of part of a coordinated retirement master plan. Because in retirement, small tax decisions compound just like investment returns may do. And when handled intentionally, RMDs don't have to derail anything at all. Don't forget to leave a rating for the “Retire Today” podcast if you've been enjoying these episodes! Subscribe to Retire Today to get new episodes every Wednesday. Apple Podcasts: https://podcasts.apple.com/us/podcast/retire-today/id1488769337  Spotify Podcasts: https://bit.ly/RetireTodaySpotify About the Author: Jeremy Keil, CFP®, CFA is a retirement financial advisor with Keil Financial Partners, author of Retire Today: Create Your Retirement Income Plan in 5 Simple Steps, and host of the Retirement Today blog and podcast, as well as the Mr. Retirement YouTube channel. Jeremy is a contributor to Kiplinger and is frequently cited in publications like the Wall Street Journal and New York Times. Additional Links: – Buy Jeremy's book – Retire Today: Create Your Retirement Master Plan in 5 Simple Steps – “5 RMD Mistakes That Could Cost You Big-Time: Even Seasoned Retirees Slip Up” by Jeremy Keil, Kiplinger Magazine – https://www.kiplinger.com/retirement/required-minimum-distributions-rmds/rmd-mistakes-that-even-seasoned-retirees-can-make – Create Your Retirement Master Plan in 5 Simple Steps – 5StepRetirementPlan.com  Connect With Jeremy Keil: Keil Financial Partners LinkedIn: Jeremy Keil Facebook: Jeremy Keil LinkedIn: Keil Financial Partners YouTube: Mr. Retirement Book an Intro Call with Jeremy's Team Media Disclosures: Disclosures This media is provided for informational and educational purposes only and does not consider the investment objectives, financial situation, or particular needs of any consumer. Nothing in this program should be construed as investment, legal, or tax advice, nor as a recommendation to buy, sell, or hold any security or to adopt any investment strategy. The views and opinions expressed are those of the host and any guest, current as of the date of recording, and may change without notice as market, political or economic conditions evolve. All investments involve risk, including the possible loss of principal. Past performance is no guarantee of future results. Legal & Tax Disclosure Consumers should consult their own qualified attorney, CPA, or other professional advisor regarding their specific legal and tax situations. Advisor Disclosures Alongside, LLC, doing business as Keil Financial Partners, is an SEC-registered investment adviser. Registration does not imply a certain level of skill or expertise. Advisory services are delivered through the Alongside, LLC platform. Keil Financial Partners is independent, not owned or operated by Alongside, LLC. Additional information about Alongside, LLC – including its services, fees and any material conflicts of interest – can be found at https://adviserinfo.sec.gov/firm/summary/333587 or by requesting Form ADV Part 2A. The content of this media should not be reproduced or redistributed without the firm’s written consent. Any trademarks or service marks mentioned belong to their respective owners and are used for identification purposes only. Additional Important Disclosures

What if home care were designed around service, trust, and human dignity—not just necessity?On The Matt Feret Show, Matt Feret speaks with Amrit Dhaliwal, CEO of Walfinch, about rethinking home care through the lens of hospitality, leadership, and intentional service design. While healthcare systems differ between the UK and the US, this conversation focuses on universal lessons families can apply anywhere.They explore how high-quality home care supports older adults in staying at home longer, why communication and continuity matter, how technology can strengthen trust with families, and what leadership systems are required to scale care without losing personalization.Whether you're caring for aging parents, planning ahead, or evaluating home care options, this episode offers practical insight into how care can help people not just age—but thrive.My website with more Medicare resources, books, courses, and more: https://prepareformedicare.comI recommend my wife's Medicare insurance agency, but there's never any obligation or pressure to work with her team. Here's more information if you're interested: https://brickhouseagency.comThe Matt Feret Show is about thriving in midlife, retirement, and beyond. Each week, Matt shares smart conversations on Medicare, Social Security, retirement planning, health, wealth, wellness, caregiving, and life after 50.Explore more episodes and sign up for The Matt Feret Newsletter: TheMattFeretShow.comNeed Medicare help? Book a no-obligation consultation: BrickhouseAgency.comWatch full episodes on YouTube: The Matt Feret ShowSubscribe on Apple, Spotify, or YouTube for more insights on wealth, wisdom, and wellness in retirement. Hosted on Acast. See acast.com/privacy for more information.

Health Affairs' Rob Lott interviews So-Yeon Kang of Georgetown University about her recent paper exploring trends in biopharmaceutical clinical trials after The Inflation Reduction Act of 2022 authorized Medicare to negotiate prices for selected drugs. Order the January 2026 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast

In this episode of the America's Work Force Union Podcast, we examine the intersection of trade policy, healthcare funding and the rising tide of union organizing across the United States. Segment 1: The High Cost of Broad Tariffs Retired International Association of Machinists and Aerospace Workers (IAM) International President Tom Buffenbarger joins host Ed “Flash” Ferenc to break down the real-world impact of sweeping tariffs. Buffenbarger explains why broad trade penalties often function as a "consumer tax" that destabilizes North American supply chains, particularly in the aerospace and automotive sectors. He also discusses the recent surge in union membership—reaching a 16-year high—and why younger workers and federal employees (NFFE) are leading the charge for collective action. Segment 2: California's Healthcare Staffing Crisis Guillermo Mendoza-Luján, Secretary-Treasurer of SEIU 121RN, sounds the alarm on hospital layoffs and staffing shortages in Southern California. Following funding cuts to Medi-Cal and Medicare, facilities like Pomona Valley Hospital Medical Center are reducing staffing levels, leading to longer ER wait times and dangerous nurse-to-patient ratios. Mendoza-Luján details the ongoing strike at Providence Cedars-Sinai Tarzana and explains why patient safety is inseparable from worker protections.

That retirement balance might look “double‑stuffed,” but the number you keep can be very different from the number you see. In this episode, Jim Fox breaks down why gross account values don’t tell the full story once taxes, Medicare surcharges, and withdrawal timing enter the picture. He explains how last‑minute financial decisions can create unintended consequences, why net income matters more than headline balances, and how mapping tax impacts helps clarify real‑world outcomes. The conversation focuses on intentional planning, avoiding surprise penalties, and understanding how everyday decisions affect the money that actually lands in your pocket. Ready to connect with Jim today? Get some Financial Straight Talk! Follow us on social media: YouTube | FacebookSee omnystudio.com/listener for privacy information.

Understanding State of Michigan Retirement Benefits: Pension vs. Defined Contribution and Health Care Options If you work for the State of Michigan, your retirement benefits can feel like a maze. Hire dates matter. Plan elections matter. Even health care decisions from years ago still matter today. In this episode of Kitchen Table Finance, Nick and Dave sit down at the table to break it all down in practical, everyday language. We walk through how to figure out what plan you are in, what your options mean, and how to think about retirement income and health care with clarity and confidence. If you have ever looked at your benefits statement and thought, where do I even start, this conversation is for you. Watch the full episode HERE. How to Determine Which Retirement Plan You Are In The first step is understanding your hire date and whether you made any elections when changes were introduced in 1997 and 2011. The three primary categories are: Defined Benefit Pension Plan Defined Contribution with Subsidized Retiree Insurance Defined Contribution with Personal Health Care Fund Nick and Dave walk through how these plans evolved over time and why your employment history determines which system you fall into. When in doubt, the Michigan Office of Retirement Services can confirm your status. Defined Benefit Pension Plan Explained A defined benefit plan provides a lifetime monthly income based on a formula. Your pension is typically calculated using: Final average compensation Pension multiplier Years of service You do not manage investments inside the pension. The State assumes the investment risk, and you receive a steady payment for life. We also discuss spousal election options, how benefits are reduced based on survivor coverage, and how to think through those decisions as part of a broader retirement plan. Defined Contribution Plan Overview A defined contribution plan works more like a 401k. You contribute a percentage of your salary, and the State provides a match. The structure generally includes: 4 percent automatic State contribution 100 percent match on up to 3 percent employee contribution From there, your retirement outcome depends on contributions, investment performance, and distribution strategy. We also cover: Traditional vs. Roth 401k contributions The 457 plan and its early withdrawal flexibility In plan Roth conversions Investment options through Voya The self directed brokerage window through Schwab Vesting Rules You Need to Know For pension participants, full vesting typically requires: Age 60 with 10 years of service Or age 55 with 30 years of service For defined contribution participants: Your contributions are always 100 percent vested Employer contributions vest 50 percent after 2 years 75 percent after 3 years 100 percent after 4 years Understanding vesting is critical if you are considering a career change before retirement. Retiree Health Care: What Changes in Retirement Health care is one of the biggest retirement stress points, especially for those retiring before Medicare. There are two primary paths: Subsidized Retiree Insurance The State continues to offer coverage in retirement and pays a percentage of your premiums based on your service years. This provides guaranteed coverage and predictable cost sharing, which can bring peace of mind for many retirees. Personal Health Care Fund Instead of subsidized insurance, the State contributes additional money into your defined contribution account. You are responsible for securing your own coverage, whether through: The health care marketplace before age 65 Medicare and supplemental coverage after age 65 We discuss why health insurance planning today is more flexible than it was 15 years ago and how proper planning can reduce the stress around this decision. Key Takeaways from This Episode Your hire date drives your retirement structure Pension and defined contribution plans operate very differently Health care decisions significantly impact retirement cash flow Early retirement requires careful coordination of 401k and 457 rules Working with a fiduciary planner can help you avoid costly mistakes State of Michigan retirement benefits are complex, but they are manageable with the right guidance and a clear strategy. If you would like help understanding how your benefits fit into your overall retirement plan, we are here to help. Contact SRB today at 517-321-4832 or email us at info@srbadvisors.com.Don't forget to subscribe to our channel for more bite-sized financial and retirement tips. Other Podcasts Referenced in This Episode S5E3 – MSU Retirement Plans Explained S4E19 – Does your Retirement Plan Need a ROTH? Medicare Planning with Justine Bell from Benny Guides  

Part 2: Bishop Robert Barron, one of the most influential Catholic voices in the world today, sits down with Dr. Phil to discuss the threats to religious liberty Americans are facing. Bishop Barron will discuss why he believes there has been an increasing rise in the practice of religion in America, especially among a younger generations, Bishop Barron will also discuss the criticism he has faced publicly by accepting to serve on President Donald Trump's Religious Liberty Commission, a position Dr. Phil has also been appointed to share alongside him, and the other distinguished members.Thank you to our sponsor: Preserve Gold - text "ASK PHIL" to 50505 and go to https://DrPhilGold.com Thank you to our sponsor: Chapter: Don't wait! If you're on Medicare or will be soon, reach out to Chapter. Call: (352)-845-0659 or go to https://askchapter.org/ to learn about your Medicare options and get help finding ways to save money.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

MeidasTouch host Ben Meiselas reports on Donald Trump's lawyers admitting his new tariff plan under the 1974 Trade Act Section 122 are illegal. For free and unbiased Medicare help, dial 82-MEDICARE (826-334-2273) to speak with our trusted partner, Chapter, or go to https://askchapter.org/mtn Visit https://meidasplus.com for more! Remember to subscribe to ALL the MeidasTouch Network Podcasts: MeidasTouch: https://www.meidastouch.com/tag/meidastouch-podcast Legal AF: https://www.meidastouch.com/tag/legal-af MissTrial: https://meidasnews.com/tag/miss-trial The PoliticsGirl Podcast: https://www.meidastouch.com/tag/the-politicsgirl-podcast The Influence Continuum: https://www.meidastouch.com/tag/the-influence-continuum-with-dr-steven-hassan Mea Culpa with Michael Cohen: https://www.meidastouch.com/tag/mea-culpa-with-michael-cohen The Weekend Show: https://www.meidastouch.com/tag/the-weekend-show Burn the Boats: https://www.meidastouch.com/tag/burn-the-boats Majority 54: https://www.meidastouch.com/tag/majority-54 Political Beatdown: https://www.meidastouch.com/tag/political-beatdown On Democracy with FP Wellman: https://www.meidastouch.com/tag/on-democracy-with-fpwellman Uncovered: https://www.meidastouch.com/tag/maga-uncovered Coalition of the Sane: https://meidasnews.com/tag/coalition-of-the-sane Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

In the first part of this three-part series, Dr. Stacey Clardy and Max Goldman discuss the state of Medicare in 2026. Stay updated with everything related to Neurology on the Hill. Show transcript: Dr. Stacey Clardy: Hi, this is Stacey Clardy. Today, we're going to start the first of a three-part series about the top advocacy issues at Neurology on the Hill 2026 in Washington, DC. As many of you know, this is the AAN's Annual Advocacy fly-in event in the US, where neurologists come to Washington and meet with our elected representatives to discuss the issues that are important for all of us in the US to continue providing high-quality care to patients with neurological diseases. Every year in preparation for this event, the AAN selects a few issues to focus on with our lawmakers, and we're going to cover those in a three-minute series. We have Max Goldman, the Director of Congressional Affairs from the AAN Legislative Team, to give us the details. Max, the first topic that will be covered at Neurology on the Hill this year is Medicare. What do we need to know about the state of Medicare in 2026? Max Goldman: Thank you so much for having me. As many of you know, the way the Medicare physician fee schedule works and the way that you all are reimbursed for the care you provide patients across the country has been broken for several years. We have this cycle of indiscriminate cuts that keeps happening, where the CMS will present a fee schedule, it'll have a cut for you all, then we have to go to Congress to beg for them to fix the cut. This year, we are talking to Congress about a structural reform that they can make, so we don't have to do that anymore, and the reimbursement that you all receive is commensurate with cost of actually providing care. This year we're going to ask for two things. We're going to ask for them to adjust the triggers to the budget neutrality requirement in the fee schedule, meaning that CMS can make some more changes to the fee schedule without requiring cuts to everyone's reimbursement, and we're going to request that they provide a permanent inflationary adjustment to physician reimbursement so that the reimbursement you get is in track with the cost of providing care in any given year. Dr. Stacey Clardy: Thanks for that summary. Here's hoping to get some traction on that. To learn more about this issue, you can go to aan.com and click on advocacy. And in the upcoming two minutes, we are going to discuss the other issues being brought to Congress at Neurology on the Hill. Thank you for listening to today's Neurology Minute. 

Vitamin D testing is vital for tailoring doses to optimize health—but regulators are conducting a campaign to deny coverage; Can magnesium be taken simultaneously with blood pressure meds? Lifelong learning delays Alzheimer's onset by 5 years; Your MRI says you have a bum shoulder—but 99% of people show abnormalities even when they have no discomfort; Saunas can help stave off dementia. 

Welcome to another episode of the Sustainable Clinical Medicine Podcast! Our host Dr. Sarah Smith interviews Coleman Associates staff Amanda Laramie and Chief Innovation Officer Adrienne Mann about how Coleman Associates helps healthcare clinics—especially community health centers—redesign care delivery through their Dramatic Performance Improvement (DPI) methodology. Adrienne describes how Coleman's work in her Chicago community health center targeted goals such as cycle time under 30 minutes (from patient arrival to departure), no-show rate under 5%, and 100% real-time charting completion, leading to improved patient and staff satisfaction and reduced burnout. They explain cycle time as a measure of organized care and patient experience, and discuss how patient visit tracking reveals bottlenecks, handoffs, and physical-layout issues that slow flow. They cover strategies to reduce no-shows, framing them as a sign of a broken relationship and an access problem; examples include mystery shopper calls to identify barriers like long hold times, easier cancellation processes, and proactive visit confirmation and preparation. They discuss role realignment and preparing for visits through team-based workflows, including the “sheep-shepherd model” where MAs or nurses shepherd clinic flow to protect clinician time, reduce interruptions, and support “today's work done today.” Specific tactics include team “dance steps,” robust intake and concise handoffs, the “midway knock” check-in (physical or virtual), and having staff “bodyguard” clinicians while charting to prevent interruptions and avoid getting behind on notes. They also discuss inbox/worklist overload, aiming for net-zero inbox at day's end through better routing/oversight, team support for tasks, and a “red carpet exit” to reduce follow-up calls by addressing questions and ensuring orders/referrals are completed before the patient leaves. The conversation addresses individual needs and disabilities (including neurodiversity), emphasizing that frontline staff should design and adapt solutions; examples include noise-canceling headphones for charting and using space creatively (e.g., an exam room as a quiet charting space). They discuss shifting visit prep from clinicians to teams so multiple “brains” are aware of patient needs (e.g., hospital follow-ups, missing labs, forms), including pre-visit calls asking about ED visits, specialists, and concerns. They argue checkbox-heavy requirements (e.g., Medicare-related items) should be handled by nurses or staff through pre-visit “concierge” workflows, and note EHR limitations can be addressed through optimization and interdisciplinary decisions about filing and access. They conclude by encouraging curiosity and questioning existing systems (“why” thinking), noting that everything is changeable except load-bearing walls, and provide ways to find Coleman Associates online. They state they primarily work across the U.S. but are open to working anywhere, including Canada and Australia. Here are 3 key takeaways from this episode: Cycle Time Under 30 Minutes Indicates Organized Care: Cycle time (patient arrival to departure) isn't about rushing—it's about eliminating confusion, handoffs, and mishaps. Shorter cycle times mean better-organized care that respects patients' time, especially those without PTO or childcare access. The goal is efficiency through coordination, not speed through corners cut. No-Shows Signal Broken Relationships, Not Patient Irresponsibility: When no-show rates exceed 10-15%, it reveals systemic issues: long hold times making cancellations difficult, appointments booked months in advance, or lack of relationship-building. The solution involves confirmation calls, easier cancellation processes, and recognizing that patients who no-show often need care the most—they're the ones appearing in emergency departments instead. The Shepherd-Sheep Model Empowers Teams and Protects Clinician Focus: Medical assistants and nurses should "shepherd" the clinician's flow—staying slightly ahead, looping back to check needs, and bodyguarding charting time from interruptions. This allows clinicians to focus on what only they can do while the care team handles preparation, coordination, and protection of workflow. The result: 100% real-time charting completion becomes achievable. Meet Amanda Laramie & Adrienne Mann: Amanda is experienced in process design, training, and leadership development. Before working with Coleman, Amanda worked for a women's health center in Providence, Rhode Island. She was a Medical Assistant and later, a Health Center Manager. Amanda has been working with Coleman Associates since 2011 and has coached hundreds of health center teams. She is a team leader and current COO of Coleman Associates. Adrienne Mann is a dynamic coach, trainer, healthcare leader, speaker, and podcast host passionate about driving positive change. She develops training on succeeding in Alternative Payment Models and leadership. As a Step-In Executive, Adrienne helps organizations tackle tough challenges. She also spearheaded Coleman Associates' IACET accreditation and Joint Accreditation, ensuring high-quality continuing education. With a background in nursing and a love for innovation, Adrienne trains national cohorts in Dramatic Performance Improvement and tracks long-term results. Her work has transformed hundreds of health centers, making a lasting impact on patient care and staff morale. She is a RN by training and current Chief Innovation office of Coleman Associates Connect with Amanda Laramie & Adrienne Mann:

In this episode, host Erin Gallardo, PT, DPT, NCS interviews the Motus Nova clinical team—occupational therapists Jamie Kurtz, MS, OTR/L, Keisha Burrous, OTR/L, CBIS, Amie Canning, MS, OTR/L, and Mirasol Jacobs, PT, DPT — about the Motus Hand and Motus Foot robotic devices for neurorehabilitation. The team explains how these FDA Class I medical devices provide active-assistive, game-based training at home to help patients achieve the high repetition doses (500–600 reps per day) needed for neuroplastic change, without replacing traditional therapy. Built on pneumatic "artificial muscle" technology, the devices adapt in real time to the user's movement, address tone and spasticity, and can be customized for a wide range of neurologic conditions, from stroke and MS to Parkinson's disease and Guillain-Barré. The conversation covers who is appropriate for the devices, how they integrate with inpatient and outpatient care, real-world success stories—including improved gait, grip strength, and mental health—and the practical steps for clinicians to refer patients, arrange demos, and navigate the 13‑month rental-to-own DME model now supported by a dedicated Medicare code, which means patients can get the device through their insurance and it does not impact their ability to get other durable medical equipment (DME). Overall, the episode highlights Motus Nova as an accessible way to extend evidence-based neuro rehab beyond the clinic and into patients' homes. You will likely have a patient (or several) who come to mind while listening to this, so check it out and learn more today! Keisha Burrous LinkedIN Motus Nova https://motusnova.com Therapists! Contact Motus Nova with questions, schedule an inservice, or refer a patient here: clinical@motusnova.com

Learn how to sponsor the Seven Figure Medicare Agent Summit:https://sevenfiguremedicareagentsummit.com/On this episode of the Seven Figures or Bust podcast, we break down the shocking news of an ACA agency being sentenced by the DOJ. We discuss what led to the case, what it means for agents in the health insurance space, and the compliance lessons everyone should be paying attention to. If you're in the industry, this is a wake-up call you can't afford to ignore.

Veronique de Rugy of the Mercatus Center explains how bipartisan spending on entitlement programs like Social Security and Medicare drives national debt, arguing that American consumers, not foreign nations, primarily bear the economic burden of tariffs. 141908 NYSE

1.Jeff Bliss reports a deadly avalanche in Lake Tahoe claimed nine lives due to dry uncompacted snow, severe storms are causing heavy snowfall at Donner Pass and flooding the Los Angeles River, while Las Vegas faces declining foot traffic and Los Angeles battles rampant copper wire theft. 12.Jeff Bliss covers California's upcoming gubernatorial jungle primary with Democrat Eric Swalwell and Republican Steve Hilton as early frontrunners, Spencer Pratt challenging Mayor Karen Bass in Los Angeles, and Governor Gavin Newsom positioning himself for a 2028 presidential run on an anti-Trump platform. 23.Gene Marks reports that despite a disappointing fourth-quarter GDP growth rate of 1.4 percent and sluggishness in shipping and chemical sectors, small businesses remain surprisingly resilient with optimism above average and continued hiring plans even as AI integration remains limited. 34.Gene Marks discusses the Supreme Court ruling the administration's April 2025 emergency tariffs unconstitutional, leaving billions in collected funds in limbo, though the administration will likely utilize the Trade Acts of 1962 and 1974 to continue imposing targeted tariffs without congressional approval. 45.Jim McTague reports Lancaster County reflects the national 1.4 percent GDP slowdown with flat retail, consumer price fatigue, and plummeting restaurant traffic due to rising costs and weight-loss drugs, while Washington DC lobbying and local health and construction sectors remain strong. 56.Lorenzo Fiori reports the Milan Winter Olympics are proceeding successfully amidst beautiful snow with rumors of a Donald Trump visit for the hockey finals, while extreme weather has caused dangerous Alpine avalanches and the tragic collapse of the historic Lover's Arch on the Adriatic coast. 67.Bob Zimmerman of Behind the Black reports NASA successfully completed a wet dress rehearsal for the Artemis IImission targeting a March 6th launch, while a NASA report classified Boeing's Starliner failure as a severe Type A emergency prompting tighter control as SpaceX competition thrives. 78.Bob Zimmerman reports Japanese private space startup ispace is struggling with severe engine development problems for its lunar landers, while archival images from New Horizons reveal Pluto's bizarre splotched surface and floating ice mountains, and a newly discovered dim galaxy hints at dark matter's vastness. 89.Sir Max Hastings details the daring glider assault to capture the Orne River bridge, where Major John Howard'stroops achieved total surprise, securing a vital link for British airborne and seaborne forces on D-Day itself. 910.Sir Max Hastings discusses General Montgomery's expanded vision for D-Day and the initial chaos of the airborne landings, noting that despite the shambles at Merville battery, paratroopers' bravery confused German defenders and secured the mission's early vital stages. 1011.Sir Max Hastings highlights Major General Richard Gale's calm leadership during the chaotic airborne drops, with success relying on British deception plans and Rommel's absence preventing early German counterattacks against the beaches on D-Day. 1112.Sir Max Hastings describes specialized armored funnies that supported British landings on Sword Beach, noting that while technically successful, heavy traffic and Montgomery's overly ambitious objectives prevented the Allies from capturing Caen on D-Day. 1213.Henry Sokolski of the Nonproliferation Policy Education Center critiques the inconsistency of threatening war against Iran over its nuclear program while simultaneously considering a deal to allow Saudi Arabia uranium enrichment capabilities under less stringent international oversight. 1314.Veronique de Rugy of the Mercatus Center explains how bipartisan spending on entitlement programs like Social Security and Medicare drives national debt, arguing that American consumers, not foreign nations, primarily bear the economic burden of tariffs. 1415.Professor Richard Epstein of the Hoover Institution analyzes constitutional limits of presidential authority to fire independent agency officials, discussing historical precedents like Humphrey's Executor and critiquing legal reasoning behind maintaining quasi-judicial independence within the executive branch. 1516.Professor Richard Epstein predicts the Supreme Court may strike down tariffs, arguing that trade deficits do not constitute legal emergencies, while also discussing the potential for the Court to preserve the Federal Reserve'sindependence from executive control. 16

Following Former President Barack Obama's bashing of U.S. Immigration and Customs Enforcement, I'm sitting down with immigration attorney Deron Smallcomb for a data-driven reality check. How does U.S. immigration enforcement actually compare to other democracies? If America enforced immigration the way the UK, Australia, or Japan do, arrests would move faster, deportations would happen sooner, and appeals would be far more limited. We're breaking down:• Appeal rights in the U.S. vs. peer nations• Asylum approval rates• Enforcement timelines• Crime outcomes in countries with stricter policiesYou can debate policy. But let's debate facts. Watch the full conversation — then decide for yourself.Thank you to our sponsor: Preserve Gold - text "ASK PHIL" to 50505 and go to https://DrPhilGold.comThank you to our sponsor: Chapter: Don't wait! If you're on Medicare or will be soon, reach out to Chapter. Call: (352)-845-0659 or go to https://askchapter.org/ to learn about your Medicare options and get help finding ways to save money.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In the final part of Episode 279 of Mike Drop, Mike Ritland and Congressman Dan Crenshaw wrap up their discussion. Crenshaw addresses federal spending, waste vs. fraud in entitlements like Social Security and Medicare, the unsustainable path of these programs, and why meaningful reform remains politically toxic. The conversation shifts to foreign policy—Ukraine aid, Israel support, deterring China over Taiwan, cartel threats, and U.S. involvement abroad—before touching on immigration enforcement, regrets, and reflections on public service. Learn more about your ad choices. Visit podcastchoices.com/adchoices